Ngoi NYL, Choi CH, Zhu J, Lim D, et al. Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trial. Clin Cancer Res 2025 Jul 24. doi: 10.1158/1078-0432.CCR-25-0201.
PMID: 40705396